NCT00553189View on ClinicalTrials.gov

Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 9, 2007

Primary Completion Date

February 1, 2008

Study Completion Date

September 28, 2011

Conditions
Solid TumorsLymphomas
Interventions
DRUG

ABT-888

DRUG

Topotecan

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00553189 - Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas | Biotech Hunter | Biotech Hunter